Stockreport

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Launch One Acquisition Corp. - Class A Ordinary Shares  (LPAA) 
PDF HAIFA, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) --  Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel thera [Read more]